IRIS
ANZINI, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.558
EU - Europa 9.532
AS - Asia 4.989
SA - Sud America 802
AF - Africa 189
Continente sconosciuto - Info sul continente non disponibili 125
OC - Oceania 13
Totale 27.208
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.366
GB - Regno Unito 2.394
CN - Cina 1.947
SG - Singapore 1.460
RU - Federazione Russa 1.413
IT - Italia 1.143
IE - Irlanda 1.071
DE - Germania 950
UA - Ucraina 740
SE - Svezia 668
BR - Brasile 635
FR - Francia 539
VN - Vietnam 423
HK - Hong Kong 400
FI - Finlandia 326
KR - Corea 267
IN - India 137
CA - Canada 98
ES - Italia 76
TR - Turchia 67
ZA - Sudafrica 67
AR - Argentina 63
BD - Bangladesh 49
IQ - Iraq 44
MX - Messico 44
JP - Giappone 36
PL - Polonia 32
NL - Olanda 29
CI - Costa d'Avorio 28
CO - Colombia 28
RO - Romania 28
NG - Nigeria 25
BE - Belgio 24
EC - Ecuador 24
ID - Indonesia 24
AT - Austria 21
CZ - Repubblica Ceca 19
KE - Kenya 17
PH - Filippine 17
CL - Cile 16
VE - Venezuela 16
DZ - Algeria 14
EE - Estonia 14
MA - Marocco 14
AE - Emirati Arabi Uniti 12
SA - Arabia Saudita 12
CR - Costa Rica 11
AZ - Azerbaigian 10
PK - Pakistan 10
UZ - Uzbekistan 10
AU - Australia 9
EG - Egitto 9
EU - Europa 8
UY - Uruguay 8
KZ - Kazakistan 7
LT - Lituania 7
NP - Nepal 7
PY - Paraguay 7
CH - Svizzera 6
HN - Honduras 6
IR - Iran 6
JO - Giordania 6
TN - Tunisia 6
BB - Barbados 5
DO - Repubblica Dominicana 5
MY - Malesia 5
DK - Danimarca 4
GR - Grecia 4
GT - Guatemala 4
HU - Ungheria 4
IL - Israele 4
JM - Giamaica 4
LK - Sri Lanka 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
PT - Portogallo 4
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
KG - Kirghizistan 3
OM - Oman 3
PE - Perù 3
TH - Thailandia 3
AO - Angola 2
GE - Georgia 2
HR - Croazia 2
KY - Cayman, isole 2
PA - Panama 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
Totale 27.075
Salva come PNG Salva come JPEG
Città #
Southend 2.124
Dallas 1.204
Fairfield 1.160
Dublin 1.064
Ashburn 878
Singapore 841
Chandler 607
Jacksonville 606
Santa Clara 542
Woodbridge 503
Wilmington 478
San Jose 471
Beijing 430
Seattle 415
Houston 404
Cambridge 391
Milan 382
Moscow 380
Hong Kong 378
Hefei 346
Ann Arbor 324
Seoul 264
Munich 253
Siena 231
Council Bluffs 226
Princeton 224
Nanjing 214
Helsinki 178
Los Angeles 157
Ho Chi Minh City 142
The Dalles 125
Menlo Park 123
Lauterbourg 119
Hanoi 117
Rome 110
Boardman 104
New York 99
Fremont 89
Buffalo 77
Shanghai 72
Shenyang 69
São Paulo 68
Nanchang 67
San Diego 67
Dearborn 57
Bengaluru 56
Lancaster 49
Málaga 48
Johannesburg 47
Orem 42
San Mateo 42
Tianjin 42
Izmir 40
Hebei 39
London 39
Düsseldorf 38
Frankfurt am Main 32
Columbus 31
Norwalk 31
Changsha 30
Florence 30
Jiaxing 29
Abidjan 28
Philadelphia 28
Jinan 27
San Francisco 27
Turin 27
Kunming 26
Venezia 25
Brussels 24
Figino 24
Tokyo 24
Washington 24
Redwood City 23
Chicago 22
Mestre 22
Stockholm 22
Toronto 21
Turku 21
Abuja 20
Vienna 20
Zhengzhou 20
Atlanta 19
Brooklyn 19
Montreal 19
Ningbo 19
Phoenix 18
Amsterdam 17
Haiphong 17
Rio de Janeiro 17
Timisoara 17
Belo Horizonte 16
Baghdad 15
Guangzhou 15
Warsaw 15
Boston 14
Brno 14
Hangzhou 14
Chennai 13
Dong Ket 13
Totale 18.611
Salva come PNG Salva come JPEG
Nome #
1,5-Diarylpyrrole-3-acetic Acids and Esters as Novel Classes of Potent and Highly Selective Cyclooxygenase-2 Inhibitors 553
Development of Potent Inhibitors of the Mycobacterium tuberculosis Virulence Factor Zmp1 and Evaluation of Their Effect on Mycobacterial Survival inside Macrophages 406
Design, Synthesis, and Biological Evaluation of Imidazo[1,5-a]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors 403
Anionic Polymerization of a Benzofulvene Monomer Leading to a Thermoreversible π-Stacked Polymer. Studies in Macromolecular and Aggregate Structure 363
Synthesis and biological evaluation of a new class of benzothiazines as neuroprotective agents 361
Novel analgesic/anti-inflammatory agents: 1,5-Diarylpyrrole nitrooxyethyl sulfides and related compounds as Cyclooxygenase-2 inhibitors containing a nitric oxide donor moiety endowed with vasorelaxant properties 344
Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats 343
Synthesis and Biological Evaluation of Novel Neuroprotective Pyridazine Derivatives as Excitatory Amino Acid Transporter 2 (EAAT2) Activators 338
A Nanocomposite Material Formed by Benzofulvene Polymer Nanoparticles Loaded with a Potent 5-HT3 Receptor Antagonist (CR3124) 331
Carborane-Conjugated 2-Quinolinecarboxamide Ligands of the Translocator Protein for Boron Neutron Capture Therapy 317
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 302
Development of subnanomolar-affinity serotonin 5-HT4 receptor ligands based on quinoline structures 301
Synthesis, biological evaluation and molecular modeling of novel selective COX-2 inhibitors: sulfide, sulfoxide, and sulfone derivatives of 1,5-diarylpyrrol-3-substituted scaffold 298
Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria 281
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity 280
Bivalent Ligands for the Serotonin 5-HT3 Receptor 278
Characterization of Quinoline Derivatives. II. 7-(4-methyl-1-piperazinyl)-6H-[1]benzopyrano[3,4-c]quinoline 273
Multivalent ligands for the serotonin 5-HT4 receptor 265
Characterization of persistent intramolecular C-H⋅⋅⋅X(N,O) bonds in solid state and solution 263
3-Substituted-1,5-diarly-2-alkyl-pyrroles Highly Selective and Orally Effective COX-2 Inhibitors 261
Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold 260
Antiproliferative effect of two novel COX-2 inhibitors on human keratinocytes 259
Synthesis and Spontaneous Polymerization of Oligo(ethylene glycol)-Conjugated Benzofulvene Macromonomers. A Polymer Brush Forming a Physical Hydrogel 258
Synthesis and structure–activity relationship studies in serotonin 5-HT1A receptor agonists based on fused pyrrolidone scaffolds 258
Design, Synthesis, and Biological Evaluation of AT1 Angiotensin II Receptor Antagonists Based on the Pyrazolo[3,4-b]pyridine and related Heteroaromatic Bicyclic Systems 256
5-HT and Benzodiazepine Receptor Ligands. III. Synthesis and Receptor Affinities of 1,2,4,-Triazolo[4',3':1,6]pyridazino[4,5-b]quinoline and 2,3-Dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinoline-1-one Derivatives 254
Novel Analgesic/Anti-inflammatory Agents: 1,5-Diarylpyrrole Nitrooxyalkyl Ethers and Related Compounds as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors 254
6-(1-Piperazinyl)-7H-indeno[2,1-c]quinoline Derivatives with High Affinity and Selectivity for 5-HT3 Serotonin Sites 253
The novel anti-inflammatory agent VA694, endowed with both NO-releasing and COX2-selective inhibiting properties, exhibits NO-mediated positive effects on blood pressure, coronary flow and endothelium in an experimental model of hypertension and endothelial dysfunction 248
Amidine, Thiourea and Guanidine Derivatives of 2-Aminobenzothiazoles and Aminobenzothiazines, Novel Pharmacological Agents for the Treatment of Neurodegenerative Pathologies 247
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 246
Dendrimeric tetravalent ligands for the serotonin-gated ion channel 246
Development of a CE method for the determination of mycophenolic acid in human plasma: A comparison with HPLC 243
Design, Synthesis, and Preliminary Biological Evaluation of Pyrrolo[3,4-c]quinolin-1-one and Oxoisoindoline Derivatives as Aggrecanase Inhibitors 243
A Computational Model of the 5-HT3 Receptor Extracellular Domain: Search for Ligand Binding Sites 240
Characterization of Quinoline Derivatives. I. 6,7-Dihydro-8-(4-methyl-1-piperazinyl)[1]benzoxepino[4,5-c]quinoline 0.13-Hydrate 236
Design, Synthesis, and Structure-Affinity Relationship Studies in NK1 Receptor Ligands Based on Azole-Fused Quinolinecarboxamide Moieties 235
Physicochemical and biopharmaceutical characterization of endo-2-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1H-benz[e]isoindol-1-one (CR3124) a novel potent 5-HT3 receptor antagonist 235
5,6-Dihydro-5-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butyl]-4H- pyrrolo[1,2-a][1,4]benzodiazepine-4,6-dione and Related Compounds as New 5-HT1A Receptor Ligands 233
Structural Manipulation of Benzofulvene Derivatives Showing Spontaneous Thermoreversible Polymerization. Role of the Substituents in the Modulation of Polymer Properties 231
11C-Labelling of the 5-HT3 Antagonist VC125 for PET Distribution Studies 227
Phenylindenone isomers as divergent modulators of p38α MAP kinase 225
Novel multitarget directed ligands inspired by riluzole: A serendipitous synthesis of substituted benzo[b][1,4]thiazepines potentially useful as neuroprotective agents 223
Enlarging the NSAIDs Family: Ether, Ester and Acid Derivatives of the 1,5-Diarrylpyrrole Scaffold as novel anti-inflammatory and analgesic agents 222
Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors 220
Synthesis and Structure-Activity Relationship Studies in Translocator Protein Ligands Based on a Pyrazolo[3,4-b]quinoline Scaffold 215
Antiamnestic Effect of the Two Novel k-Opioid Agonists, VA-100 and VA-101, in the Mouse Passive Avoidance Test 212
Nitroesteri di 1,5-Diaril-2-alchil-pirroli-3-sostituiti,Inibitori Selettivi di COX-2 e Donatori di Ossido Nitrico 211
Synthesis and biological evaluation of amidine, guanidine, and thiourea derivatives of 2-amino(6-trifluoromethoxy)benzothiazole as neuroprotective agents potentially useful in brain diseases 209
Synthesis of 2-Substituted-2,3-dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinolin-3-ones as Potential Peripheral Benzodiazepine-receptor Ligands 208
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 208
Cyclooxygenase-2 Inhibitors. 1,5-Diarylpyrrol-3-acetic Esters with Enhanced Inhibitory Activity Toward Cyclooxygenase-2 and Improved Cyclooxygenase-2/Cyclooxygenase-1 Selectivity 207
Mapping the Peripheral Benzodiazepine Receptor Binding Site by Conformationally Restrained Derivatives of 1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK11195) 205
Synthesis of 6-(4-Methyl-1-piperazinyl)-7H-indeno[2,1-c]quinoline Derivatives as Potential 5-HT Receptor Ligands 205
Synthesis, Labeling, and Biological Evaluation of Halogenated 2-Quinolinecarboxamides as Potential Radioligands for the Visualization of Peripheral Benzodiazepine Receptors 204
Chondroprotective effect of three different classes of anti-inflammatory agents on human osteoarthritic chondrocytes exposed to IL-1β. S. Cheleschi, N. A. Pascarelli, G. Valacchi, A. Di Capua, M. Biava, G. belmonte, A. Giordani, C. Sticozzi, M. Anzini, A. Fioravanti 204
Synthesis of 6,7-Dihydro-8-(4-methyl-1-piperazinyl)-[1]benzoxepino[4,5-c]quinoline as Potential 5-HT3 Receptor Ligand 203
Novel and Highly Potent 5-HT3 Receptor Agonists Based on a Pyrroloquinoxaline Structure 201
Novel Analgesic/Anti-inflammatory Agents: Diarylpyrrole Acetic Esters Endowed with Nitric Oxide Releasing Properties 201
Synthesis of trifluoromethyl-substituted pyrazolo[4,3-c]pyridines - Sequential versus multicomponent reaction approach 200
Synthesis, Biological Evaluation, and Quantitative Receptor Docking Simulations of 2-Acylaminoethyl-1,4-benzodiazepines as novel Tifluadom-Like Ligands with High Affinity and Selectivity for k-Opioid Receptors 200
Synthesis, Biological Evaluation, and Enzyme Docking Simulations of 1,5-Diarylpyrrole-3-Alkoxyethyl Ethers as Selective Cyclooxygenase-2 Inhibitors Endowed with Anti-inflammatory and Antinociceptive Activity 199
Mapping and Fitting the Peripheral Benzodiazepine Receptor Binding Site by Carboxamide Derivatives. Comparison of Different Approaches to Quantitative Ligand-Receptor Interaction Modeling 199
In Vitro Effects of VA441, a New Selective Cyclooxygenase-2 Inhibitor, on Human Osteoarthritic Chondrocytes exposed to IL-1β 198
Novel Basic Derivatives of Benz[e]isoindol-1-ones and Pyrrolo[3,4-c]quinolin-1-ones with 5-HT3 Antagonistic Activity, their Preparation and their Therapeutic Use 198
Molecular Basis of Peripheral vs Central Benzodiazepine Receptor Selectivity in a New Class of Peripheral Benzodiazepine Receptor Ligands Related to Alpidem 197
Structure-Activity Relationships in Carboxamide Derivatives Based on the Targeted Delivery of Radionuclides and Boron Atoms by Means of Peripheral Benzodiazepine Receptor Ligands 196
New red-shifted coelenterazine analogues with an extended electronic conjugation 195
New π-stacked benzofulvene polymer showing thermoreversible polymerization: studies in macromolecular and aggregate structures and polymerization mechanism 194
Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffolds 193
Synthesis and Characterization of a New Benzofulvene Polymer Showing a Thermoreversible Polymerization Behavior 192
Characterization of Quinoline Derivatives. Part 3. Mass Spectrometry and X-ray Crystallography of Biologically Interesting Arylquinolines 192
Synthesis of 1,2,4,-Triazolo[4',3':1,6]pyridazino[4,5-b]quinoline Derivatives 191
Characterization and Differentiation of Heterocyclic Isomers. Part 2. Mass Spectrometry and Molecular Orbital Calculations on Pyrrolo[1,2-a][1,4]benzodiazepin-4-one, -6-one, -4,6-dione 191
Heterotricyclic Amide Derivatives as Neurokinin-1 (NK1) Receptor Ligands 189
Esteri di Acidi Grassi Insaturi e Ormoni Androgeni Potenzialmente utili nel Trattamento del Dolore 189
Multivalent Supramolecular Dendrimer-Based Drugs 188
Ethyl 8-Fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as Novel, Highly Potent, and Safe Antianxiety Agent 188
Synthesis, in vitro, and in vivo biological evaluation and molecular docking simulations of chiral alcohol and ether derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents 187
Determination of a novel angiotensin-AT1 Antagonist CR3210, in biological samples by HPLC 185
New Insight into the Central Benzodiazepine Receptor-Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and Related Compounds 185
Polycondensed heterocycles. III. Synthesis of 5,11-dioxo-1,2,3,11a-tetrahydro-5H,11H- and 5-oxo-2,3,11,11a-tetrahydro-1H,5H-pyrrolo[2,1-c][1,4]benzothiazepine 184
Radiosynthesis of [11C]-Labelled COX-2 Selective Inhibitor as a Potential PET Tracer Candidate for Cyclooxigenase-2 Expression 184
CoMFA Analysis of Ligands of the Mitochondrial Benzodiazepine Receptor: A Versatile Tool for the Design of New Lead Compounds 180
Hyaluronan graft copolymers bearing fatty-acid residues as self-assembling nanoparticles for olanzapine delivery 180
Enantioresolution and stereochemical characterization of two chiral sulfoxides endowed with COX-2 inhibitory activity 176
Molecular Structure and Dynamics of Some Potent 5-HT3 Receptor Antagonists. Insight into the Interaction with the Receptor 174
Polycondensed heterocycles. VII. A convenient synthesis of pyrrolo[1,2-a]quinoxaline derivatives by intramolecular aromatic nucleophilic displacement 174
Design, Synthesis, Structural Studies, Biological Evaluation, and Computational Simulations of Novel Potent AT1 Angiotensin II Receptor Antagonists Based on the 4-Phenylquinoline Structure 173
Synthesis, Resolution, and Absolute Configuration of Two Novel and Selective Cyclooxygenase-2 Inhibitors Based on 1,5-Diarylpyrrole Structure 172
Further Studies on the Interaction of 5-Hydroxytryptamine3 (5-HT3) Receptor with Arylpiperazine Ligands. Development of a New 5-HT3 Receptor Ligand Showing Potent Acetylcholinesterase Inhibitory Properties 171
Use of imidazo[1,5-a]quinoline scaffold as the pharmacophore in the design of bivalent ligands of central benzodiazepine receptors 169
Structure–affinity relationship studies on arylpiperazine derivatives related to quipazine as serotonin transporter ligands. Molecular basis of the selectivity SERT/5-HT3 receptor 169
Synthesis, Biological Evaluation and Receptor Docking Simulations of 2-[(Acylamino)ethyl]-1,4-benzodiazepines as k-Opioid Receptor Agonists Endowed with Antinociceptive and Antiamnestic Activity 168
Synthesis and Biological Characterization of Novel 2-Quinolinecarboxamide Ligands of the Peripheral Benzodiazepine Receptors Bearing Technetium-99m or Rhenium 166
Novel polybenzofulvene derivatives: synthesis and uses thereof 166
Novel potent 5-HT3 receptor ligands based on the pyrrolidone structure: synthesis, biological evaluation, and computational rationalization of the ligand-receptor interaction modalities 166
Synthesis and structure-activity relationship studies in peripheral benzodiazepine receptor ligands related to alpidem 163
Radiosynthesis and preclinical evaluation of 11C-VA426, a cyclooxygenase-2 selective ligand 162
Novel Potent and Selective 5-HT3 Receptor Antagonists Based on Arylpiperazine Skeleton: Synthesis, Structure, Biological Activity and CoMFA Studies 161
Totale 23.010
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.163
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.164 0 0 0 200 64 35 79 47 67 201 147 324
2022/20232.291 136 171 301 344 241 458 50 193 209 64 85 39
2023/20241.583 55 25 186 65 46 438 517 63 0 20 18 150
2024/20253.415 69 174 290 171 395 202 142 208 303 136 337 988
2025/20267.494 564 1.142 956 796 1.311 269 832 187 273 413 152 599
2026/20271.279 316 244 649 70 0 0 0 0 0 0 0 0
Totale 27.208